We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
8.08%
Top 10 Hldgs %
37.79%
Holding
268
New
72
Increased
34
Reduced
55
Closed
76

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.3M
2
SONX
Sonendo, Inc.
SONX
+$7.34M
3
NTRA icon
Natera
NTRA
+$6.8M
4
AZTA icon
Azenta
AZTA
+$6.45M
5
QTRX icon
Quanterix
QTRX
+$5.89M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$22.4M
2
ILMN icon
Illumina
ILMN
+$11.7M
3
AZN icon
AstraZeneca
AZN
+$9.6M
4
OM icon
Outset Medical
OM
+$8.46M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.35%
2 Industrials 0.25%
3 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIVI icon
201
BioVie
BIVI
$11.8M
– –
-366
Closed -$91K
BLUE
202
DELISTED
bluebird bio
BLUE
– –
-3,980
Closed -$504K
BPMC
203
PUT
DELISTED
Blueprint Medicines
BPMC
– –
-10,000
Closed -$659K
BSX icon
204
Boston Scientific
BSX
$74.5B
– –
-48,635
Closed -$1.88M
COR icon
205
PUT
Cencora
COR
$60B
– –
-17,500
Closed -$2.37M
DNA icon
206
PUT
Ginkgo Bioworks
DNA
$486M
– –
-15,000
Closed -$1.87M
GERN icon
207
Geron
GERN
$1.01B
– –
-500,000
Closed -$1.12M
GH icon
208
PUT
Guardant Health
GH
$22.2B
– –
-400,000
Closed -$21.5M
GLSI icon
209
Greenwich LifeSciences
GLSI
$248M
– –
-19,667
Closed -$179K
GOSS icon
210
Gossamer Bio
GOSS
$86.8M
– –
-341,878
Closed -$4.1M
GOSS icon
211
PUT
Gossamer Bio
GOSS
$86.8M
– –
-169,900
Closed -$2.04M
ILMN icon
212
Illumina
ILMN
$29.1B
– –
-56,540
Closed -$11.7M
IOVA icon
213
Iovance Biotherapeutics
IOVA
$3.05B
– –
-144,528
Closed -$1.39M
IRTC icon
214
iRhythm Holdings
IRTC
$4.13B
– –
-47,521
Closed -$5.17M
IRTC icon
215
PUT
iRhythm Holdings
IRTC
$4.13B
– –
-47,000
Closed -$5.89M
KOD icon
216
CALL
Kodiak Sciences
KOD
$2.72B
– –
-200,000
Closed -$1.55M
LAB icon
217
Standard BioTools
LAB
$312M
– –
-253,132
Closed -$278K
LLY icon
218
Eli Lilly
LLY
$1.09T
– –
-2,646
Closed -$856K
MASI
219
CALL
DELISTED
Masimo
MASI
– –
-30,000
Closed -$4.24M
MASI
220
DELISTED
Masimo
MASI
– –
-25,800
Closed -$3.64M
MASS icon
221
908 Devices
MASS
$414M
– –
-55,556
Closed -$914K
MEDP icon
222
PUT
Medpace
MEDP
$16.7B
– –
-75,000
Closed -$11.8M
MGNX icon
223
MacroGenics
MGNX
$256M
– –
-52,573
Closed -$182K
MRUS
224
DELISTED
Merus
MRUS
– –
-135,632
Closed -$2.72M
MTD icon
225
PUT
Mettler-Toledo International
MTD
$28.8B
– –
-20,000
Closed -$21.7M
7 8
9
10 11

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Pura Vida Investments held 268 positions worth $1.94B, up 12% from $1.73B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments deployed $157M of net new capital in Q4 2022, opening 72 new positions and adding to 34 existing holdings. Its largest new stake was Natera: 165,000 shares worth $6.63M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 35% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was United Therapeutics, an estimated $22.4M trimmed.

  • Pura Vida Investments's largest Q4 2022 buy was Natera: 165,000 shares worth $6.63M.
  • Pura Vida Investments added most to Biogen in Q4 2022, an estimated $16.3M increase.
  • Pura Vida Investments's biggest Q4 2022 reduction was United Therapeutics, cutting an estimated $22.4M.
  • Pura Vida Investments fully exited Illumina in Q4 2022, selling an estimated $11.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $1.94B portfolio in Q4 2022.
  • Pura Vida Investments opened 72 new positions and closed 76 in Q4 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.